Valerio Therapeutics Société anonyme (EPA:ALVIO)

EPA:ALVIO Revenue

Valerio Therapeutics Société anonyme had revenue of 3.10M EUR in the half year ending June 30, 2026, with 3,385.39% growth. This brings the company's total for the last twelve months to 5.55M, up 203.22% year-over-year. In the year 2025, Valerio Therapeutics Société anonyme had annual revenue of 2.57M with 43.50% growth. That makes Valerio Therapeutics Société anonyme the 39,210th largest company in the world by revenue and 514th in France.

• Revenue (ttm): 5.55M
• Revenue Growth: +203.22%
• P/S Ratio: 35.51
• Revenue / Employee: 135.34K
• Employees: 41
• Market Cap: 197.03M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Rest of The World 1.87M 72.8%
• France 701.00K 27.2%

Fiscal year ended Dec 31, 2025 See the full EPA:ALVIO breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.57M	780.00K	43.50%
Dec 31, 2024	1.79M	-7.00K	-0.39%
Dec 31, 2023	1.80M	357.00K	24.74%
Dec 31, 2022	1.44M	-2.62M	-64.48%
Dec 31, 2021	4.06M	2.29M	128.72%

Data Source: S&P Global Market Intelligence Last updated: Oct 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error